← All organizations

Highest phase reached
Phase 2
First clinical trial
Jun 1, 2009Last known activity
Apr 28, 2025
Timeline
1990s
- Jun 1, 1999
Syntrix Biosystems, Inc.— Founded
Drugs by trial phase (10 distinct, 15 trials)
Phase 2 (8 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (22)
- NCT07002320CollaboratorPhase 1/Phase 2Apr 28, 2025
- NCT06228053Lead sponsorPhase 2Jun 5, 2024
- NCT06228053OfficialPhase 2Jun 5, 2024
- NCT05570825CollaboratorPhase 2Jan 9, 2023
- NCT05604560CollaboratorPhase 2Dec 31, 2022
- NCT04683926Lead sponsorPhase 1Dec 31, 2020
- NCT04683926Study directorPhase 1Dec 31, 2020
- NCT04477343CollaboratorPhase 1Nov 5, 2020
- NCT04599140CollaboratorPhase 1/Phase 2Oct 14, 2020
- NCT04245397Lead sponsorPhase 1Feb 29, 2020
- NCT03664921Study directorPhase 2Oct 1, 2018
- NCT03431974Lead sponsorPhase 2Oct 1, 2018
- NCT03431974Study directorPhase 2Oct 1, 2018
- NCT03664921Lead sponsorPhase 2Oct 1, 2018
- NCT03161431Lead sponsorPhase 1Dec 1, 2017
Details
- Founded
- Auburn, WA, US Jun 1, 1999
- Last known activity
- Apr 28, 2025